Once a specialist in oncology drugs and pain management, Sorrento Therapeutics (SRNE) has pivoted to attack COVID-19 head-on in 2020, offering up a smorgasbord of tests to detect the novel coronavirus, vaccines to prevent it, and therapies to combat it. As the President’s illness illustrates, the coronavirus contagion is still very much a threat — and no one is safe.With this in mind, Dawson James analyst Jason Kolbert released a note focusing in on the President’s doctors’ use of polyclonal “cocktails” of antibodies to fight the virus, and what that might mean for Sorrento Therapeutics — whose treatments haven’t been …read more
Source:: Yahoo Finance
